Interferon-β mutants with increased anti-proliferative activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 8, 2011
Grant Date -
May 14, 2009
app pub date -
Apr 9, 2008
filing date -
Sep 9, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Protease resistant modified interferon-beta polypeptides, pharmaceutical compositions and methods of treatment by administering the compositions are provided. The modified interferon-beta polypeptides are orally available; hence pharmaceutical compositions formulated for oral administration also are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully